Startup wants to advance minimally invasive device to resolve nasal obstruction
Spirox, based in Menlo Park, California, is traveling down the well-worn path of bringing a minimally invasive approach to complex surgery through a new device.
Spirox closes $45M Series C for its device used by Ear, Nose and Throat physicians
Nasal obstruction is a significant problem that effects more than three million Americans each year. Spirox is developing a minimally invasive device that would decrease the need for surgery.
presented by
Why Workflow Chaos Is Undermining Care – and What Providers Can Do About It.
Healthcare is drowning in chaos—from scattered data to burnout-inducing tasks. Discover how smarter workflows and real-time insights can rescue care teams and transform patient outcomes.